Direct-to-Consumer Lab Test Start-Up EverlyWell Puts Clinical Laboratory Tests on Shelves at CVS and Target

If direct-to-consumer testing continues to attract healthcare consumers and financial investors, medical laboratories could have a new source of revenue Many have tried but few have found the right formula to offer medical laboratory tests directly to consumers. Direct-to-consumer lab testing as a robust business model has been an elusive goal. But now one entrepreneur wants to crack this market and just attracted $50 million in venture capital to fund her idea! Outsiders often establish...

Why Clinical Laboratory Managers and Pathologists Are Using Performance Data Systems and Business Intelligence to Boost Productivity and Quality

Real-time data feeds give managers a view on turnaround time, physician ordering patterns, staffing levels, workload, specimen quality, and instrument performance Financial pressures are intensifying at the nation’s clinical laboratories. This is particularly true of the labs serving hospitals and health systems. Declining inpatient volume and less revenue per inpatient admission are reasons why hospital lab budgets are shrinking. These trends mean clinical lab administrators and pathologists...

Medical Lab Testing Company Myriad Genetics Acquires Rules-Based Medicine for $80 Million

 Pathologists take note! Companion diagnostics is the driver in this transaction. Genetic testing giant Myriad Genetics, Inc. (NASDAQ:MYGN) will pay $80 million to acquire Rules-Based Medicine (RBM) of Austin, Texas, a privately-held companion diagnostic company in a deal announced last week. Myriad Genetics, best known to pathologists and clinical laboratory managers for its portfolio of predictive genetic cancer tests, believes its purchase of Rules-Based Medicine will give it a faster entre...
;